glp 1 analog mechanism of action Mechanisms of GLP-1RA GLP-1-based therapies for type 2

Insurance Gaps Only Serve to Reinforce Inequality Access to GLP-1 medications is also shaped by the uneven landscape of insurance coverage

But weight loss is not the only metric that matters

Liraglutide users without diabetes showed higher chances of delayed gastric emptying (139%) and ileus (32%) compared to other weight loss medications

Cohort 25 adult participants Trial design Randomised crossover design Markers GLP-1, glucose, insulin & appetite Published in Journal of Obesity Weight Loss Therapy Supports healthier post-meal glucose balance ~8% Lower glucose rise at 60 mins ~9.7% Reduction at 90 mins Lower Post-meal glucose excursions observed overall A sharper spike vs

Clinical trials provide valuable perspective, but safety arises from candid discussions with a provider and transparent follow-up

Kwan EP, and Gaisano HY